Skip to main content

Table 1 Patients’ baseline characteristics

From: Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial

  CHM group placebo group
Number of subjects 7 10
Sex
 Male 7 8
 Female 0 2
Age, years (Mean, SD) 45.43, 11.84 41.60, 13.24
 Min-Max 29 to 59 24 to 62
PASI, (Mean, SD) 13.19, 3.66 11.67, 4.17
 (min-max) (10.1 to 20.4) (6.5 to 17.6)
Disease duration, months (minimum to maximum) 252 to 601 21 to 192
 (Mean, SD) 144.57, 73.77 86.20, 54.02
Job, n (%)
 Worker 2 (29) 1 (10)
 Farmer 2 (29) 1 (10)
 Cadres 0 (0) 1 (10)
 Clerk 1 (14) 5 (50)
 Retired or unemployed 0 0
 Freelance work 1 (14) 2 (20)
 Others 1 (14) 0
Marital status, n(%)
 Married 5 (63) 6 (60)
 Unmarried 3 (38) 4 (40)
Education, n(%)
 Illiterate 1 (14) 1(10)
 Middle school 2 (29) 0
 High school 3 (43) 2 (20)
 College graduate 1 (14) 7 (70)
Family history, n(%) 0  
 With 0 5 (50)
 Without 7 (100) 5 (50)
BMI, (Mean, SD) 22.76, 3.70 24.16, 2.67
Stage, n(%)
 Active 0 0
 Stable 7 (100) 10 (100)
 Regressive 0 0
  1. CHM Chinese herbal medicine, BMI body mass index, PASI Psoriasis Area Severity Index, SD standard deviation